Charles Bussell
Gastroenterology · Waco, TXNPI 1306409438
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,330 of the $5,534 with a category attached, or 60.2%. Boston Scientific accounts for 71.5% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $2,875, more than ten times the $138 reported in 2021.
Across 78 payments — averaging $70.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Phathom Pharmaceuticals, Inc.$480
- Ferring Pharmaceuticals Inc.$172
- AbbVie$129
- Ardelyx, Inc.$121
- AstraZeneca$81
- plus $596 from 16 others
What the payments were for
- Travel & lodging$2,20440%
- Food & beverage$3,33060%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $3,955 |
| Phathom Pharmaceuticals, Inc. | 22 | $480 |
| Ferring Pharmaceuticals Inc. | 2 | $172 |
| AbbVie | 2 | $129 |
| Ardelyx, Inc. | 1 | $121 |
| AstraZeneca(2 entities) | 3 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| Aimmune Therapeutics, Inc. | 3 | $61 |
| Boehringer Ingelheim | 2 | $55 |
| Johnson & Johnson | 2 | $47 |
| Madrigal Pharmaceuticals | 1 | $45 |
| Pfizer | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 1 | $32 |
| Apollo Endosurgery US Inc | 1 | $28 |
| Bayer | 1 | $26 |
| Biogen | 1 | $24 |
| Amgen | 1 | $21 |
| Enterra Medical, Inc. | 1 | $21 |
| Medtronic | 1 | $21 |
| Novartis | 1 | $20 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OverStitch Endoscopic Suturing System$1,777
- AXIOS$1,285
- VOQUEZNA$350
- GENERAL - THERAPIES$164
- REBYOTA$156
- Axonics$149
- ORISE$137
- IBSRELA$121
- Rinvoq$102
How this compares
$5,534 in reported general payments places this provider in the 65th percentile of 1,350 gastroenterology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azathioprine | 11 | $503 |
| Pantoprazole Sodium | 15 | $423 |
| Omeprazole | 16 | $318 |
| Famotidine | 16 | $301 |
| Dicyclomine Hcl | 11 | $193 |
| Furosemide | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Waco
- Nadege GunnWaco$933K
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
- Brooks CashHouston$867K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.